BILIRUBIN CONJUGATED ABNORMAL

BILIRUBIN CONJUGATED ABNORMAL was reported 111 times

These drug classes are most commonly taken by patients reporting BILIRUBIN CONJUGATED ABNORMAL:

# Drug Count
0 Corticosteroid [EPC] 14
1 Nonsteroidal Anti-inflammatory Drug [EPC] 12
2 Aromatase Inhibitor [EPC] 10
3 Bile Acid [EPC] 8
4 Complement Inhibitor [EPC] 8
5 Dihydropyridine Calcium Channel Blocker [EPC] 8
6 Platelet Aggregation Inhibitor [EPC] 8
7 Programmed Death Receptor-1 Blocking Antibody [EPC] 8
8 Benzodiazepine [EPC] 7
9 HMG-CoA Reductase Inhibitor [EPC] 7
10 P2Y12 Platelet Inhibitor [EPC] 7
11 Calcium Channel Blocker [EPC] 6
12 Loop Diuretic [EPC] 6
13 Osmotic Laxative [EPC] 6
14 Atypical Antipsychotic [EPC] 5
15 Proton Pump Inhibitor [EPC] 5
16 5-alpha Reductase Inhibitor [EPC] 4
17 Antiarrhythmic [EPC] 4
18 Expectorant [EPC] 4
19 Provitamin D2 Compound [EPC] 4
20 Aldosterone Antagonist [EPC] 3
21 Amide Local Anesthetic [EPC] 3
22 Angiotensin 2 Receptor Blocker [EPC] 3
23 Anti-epileptic Agent [EPC] 3
24 Folate Analog Metabolic Inhibitor [EPC] 3
25 Mood Stabilizer [EPC] 3
26 Potassium Salt [EPC] 3
27 Androgen [EPC] 2
28 Antidote [EPC] 2
29 Antidote for Acetaminophen Overdose [EPC] 2
30 CD52-directed Cytolytic Antibody [EPC] 2
31 Dipeptidyl Peptidase 4 Inhibitor [EPC] 2
32 Ester Local Anesthetic [EPC] 2
33 Estrogen Receptor Antagonist [EPC] 2
34 Factor Xa Inhibitor [EPC] 2
35 Histamine-2 Receptor Antagonist [EPC] 2
36 Insulin Analog [EPC] 2
37 Kinase Inhibitor [EPC] 2
38 Mucolytic [EPC] 2
39 Non-Standardized Chemical Allergen [EPC] 2
40 Peroxisome Proliferator Receptor alpha Agonist [EPC] 2
41 Platinum-based Drug [EPC] 2
42 Potassium Channel Blocker [EPC] 2
43 Purine Antimetabolite [EPC] 2
44 Rifamycin Antibacterial [EPC] 2
45 Serotonin-3 Receptor Antagonist [EPC] 2
46 Sulfonamide Antibacterial [EPC] 2
47 Vitamin B12 [EPC] 2
48 Vitamin C [EPC] 2
49 Vitamin D [EPC] 2
50 Alkylating Drug [EPC] 1
51 Aminosalicylate [EPC] 1
52 Angiotensin Converting Enzyme Inhibitor [EPC] 1
53 Anti-IgE [EPC] 1
54 Antimycobacterial [EPC] 1
55 CTLA-4-directed Blocking Antibody [EPC] 1
56 Calcineurin Inhibitor Immunosuppressant [EPC] 1
57 Dietary Cholesterol Absorption Inhibitor [EPC] 1
58 Endothelin Receptor Antagonist [EPC] 1
59 Erythropoiesis-stimulating Agent [EPC] 1
60 GLP-1 Receptor Agonist [EPC] 1
61 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
62 Human Immunoglobulin G [EPC] 1
63 Integrin Receptor Antagonist [EPC] 1
64 Interleukin-17A Antagonist [EPC] 1
65 Interleukin-2 Receptor Blocking Antibody [EPC] 1
66 Janus Kinase Inhibitor [EPC] 1
67 Microtubule Inhibitor [EPC] 1
68 Nucleoside Analog Antiviral [EPC] 1
69 Opioid Agonist [EPC] 1
70 RANK Ligand Inhibitor [EPC] 1
71 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1
72 Sulfone [EPC] 1
73 Sympathomimetic-like Agent [EPC] 1
74 Thyroid Hormone Receptor beta Agonist [EPC] 1
75 Tissue-nonspecific Alkaline Phosphatase [EPC] 1
76 Tumor Necrosis Factor Blocker [EPC] 1
77 alpha-Adrenergic Blocker [EPC] 1
78 beta-Adrenergic Blocker [EPC] 1